Your browser doesn't support javascript.
loading
Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer.
Heersche, Niels; Veerman, G D Marijn; de With, Mirjam; Bins, Sander; Assaraf, Yehuda G; Dingemans, Anne-Marie C; van Schaik, Ron H N; Mathijssen, Ron H J; Jansman, Frank G A.
Afiliación
  • Heersche N; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: n.heersche@erasmusmc.nl.
  • Veerman GDM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • de With M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Clinical Chemistry, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands.
  • Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Assaraf YG; The Fred Wyszkowski Cancer Research Laboratory, Department of Biology, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
  • Dingemans AC; Department of Pulmonary Medicine, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands.
  • van Schaik RHN; Department of Clinical Chemistry, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands.
  • Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Jansman FGA; Department of Clinical Pharmacy, Deventer Hospital, Deventer, the Netherlands; Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University Groningen, Groningen, the Netherlands.
Drug Resist Updat ; 62: 100832, 2022 05.
Article en En | MEDLINE | ID: mdl-35427871
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Drug Resist Updat Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Drug Resist Updat Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido